por
Yu, Lian-Ching,
Chang, Chao-Hsiang,
Huang, Chi-Ping,
Huang, Chao-Yuan,
Hong, Jian-Hua,
Tai, Ta-Yao,
Weng, Han-Yu,
Lo, Chi-Wen,
Tsai, Chung-You,
Lee, Yu-Khun,
Tsai, Yao-Chou,
Hsueh, Thomas Y.,
Chen, Yung-Tai,
Chen, I-Hsuan,
Chiang, Bing-Juin,
Tseng, Jen-Shu,
Wu, Chia-Chang,
Lin, Wei-Yu,
Chien, Tsu-Ming,
Sheu, Zai-Lin,
Li, Ching-Chia,
Ke, Hung-Lung,
Li, Wei-Ming,
Lee, Hsiang-Ying,
Wu, Wen-Jeng,
Yeh, Hsin-Chih
Publicado 2020
“…This retrospective study came from the Taiwan UTUC Collaboration Group, which consisted of 2658 patients at 15 institutions in Taiwan from
1988 to 2019. Patients with kidney-sparing management, both renal pelvic and ureteral tumors, as well as patients lacking complete data were excluded; the remaining 1436 patients were divided into two groups: renal pelvic tumor (RPT) and ureteral tumor (UT), with 842 and 594 patients, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto